Larazotide acetate Size:Contact [email protected] for quotation Constitutively activated mutant FLT3 has

Constitutively activated mutant FLT3 has emerged as a promising target for therapy for the subpopulation of acute myeloid leukemia (AML) patients who harbor it

It down-regulates CDK4 and cyclin D1 expression while does not effect other CDKs and cyclins

P53R3 does not exhibit cytotoxic effects even at concentrations close to its solubility limit (33 μg/ml)

29)11-7-17(21)15-2-3-20(27)30-13-15/h2-3

Larazotide acetate Size:Contact [email protected] for quotation Constitutively activated mutant FLT3 hasLarazotide acetate is a synthetic peptide. Larazotide acetate acts as a tight junction regulator and reverses leaky junctions to their normally closed state. Product information CAS Number: 881851 50 9 Molecular Weight: 785. 89 Formula: C34H59N9O12 Chemical Name: 2 {[(2S) 1 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [2 (2 aminoacetamido)acetamido] 3 methylbutanamido] 4 methylpentanamido] 3 methylbutanamido] 4 carbamoylbutanoyl]pyrrolidin 2 yl]formamido}acetic